Effram Wei

This study shows that altering glycosylation in human cells changes phosphorylation signaling networks, with engineered cells showing reduced phosphorylation responses and rewired signaling pathways.

This study shows that desialylation reduces EGFR phosphorylation and signaling by affecting specific glycoforms and phosphosites, highlighting glycan remodeling as a therapeutic strategy for RTK-driven cancers.